This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rusterholz, C.
Right arrow Articles by Nabholz, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rusterholz, C.
Right arrow Articles by Nabholz, M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 1999, p. 2681-2689, Vol. 19, No. 4
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Interleukin-2 (IL-2) Regulates the Accessibility of the IL-2-Responsive Enhancer in the IL-2 Receptor alpha  Gene to Transcription Factors

Corinne Rusterholz, Patricia Corthésy Henrioud, and Markus Nabholz*

Swiss Institute for Experimental Cancer Research (ISREC), CH-1066 Epalinges, Switzerland

Received 19 November 1998/Accepted 20 January 1999

Interleukin-2 (IL-2) responsiveness of T lymphocytes is controlled through transcription of the IL-2 receptor (IL-2R) alpha  subunit by antigen and by IL-2 itself. IL-2 induces IL-2Ralpha transcription via an IL-2-responsive enhancer (IL-2rE), whose activity depends on the cooperative binding of IL-2-induced STAT5 to two sites and of constitutively active Elf-1 to a third one. Here we describe the changes in IL-2rE chromatin that occur in normal T lymphocytes upon activation of IL-2Ralpha expression. In cells induced to transiently express IL-2Ralpha with concanavalin A (which mimics antigen), none of the IL-2rE sites is occupied despite the presence of Elf-1 and STAT1, which bind to the IL-2rE in vitro. The two STAT binding sites are occupied rapidly upon IL-2 stimulation, concomitantly with STAT5 activation. Occupation of the Elf-1 binding site is delayed, although Elf-1 concentration and binding activity are not modified by IL-2. Digestion of T-cell chromatin with DNase I and micrococcal nuclease shows that IL-2 induces the appearance of nuclease-hypersensitive sites flanking the IL-2rE. Thus IL-2, in addition to activating STAT5, appears to regulate IL-2Ralpha transcription by making IL-2Ralpha chromatin accessible to transcription factors.


* Corresponding author. Mailing address: Swiss Institute for Experimental Cancer Research (ISREC), 155 Chemin des Boveresses, CH-1066 Epalinges, Switzerland. Phone: 41 21 692-5834. Fax: 41 21 652-6933. E-mail: Markus.Nabholz{at}isrec.unil.ch.


Molecular and Cellular Biology, April 1999, p. 2681-2689, Vol. 19, No. 4
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Adler, S. H., Chiffoleau, E., Xu, L., Dalton, N. M., Burg, J. M., Wells, A. D., Wolfe, M. S., Turka, L. A., Pear, W. S. (2003). Notch Signaling Augments T Cell Responsiveness by Enhancing CD25 Expression. J. Immunol. 171: 2896-2903 [Abstract] [Full Text]  
  • Han, S. B., Park, S. H., Jeon, Y. J., Kim, Y. K., Kim, H. M., Yang, K. H. (2001). Prodigiosin Blocks T Cell Activation by Inhibiting Interleukin-2Ralpha Expression and Delays Progression of Autoimmune Diabetes and Collagen-Induced Arthritis. J. Pharmacol. Exp. Ther. 299: 415-425 [Abstract] [Full Text]  
  • Haque, A., Echchannaoui, H., Seguin, R., Schwartzman, J., Kasper, L. H., Haque, S. (2001). Cerebral Malaria in Mice : Interleukin-2 Treatment Induces Accumulation of {{gamma}}{{delta}} T Cells in the Brain and Alters Resistant Mice to Susceptible-Like Phenotype. Am. J. Pathol. 158: 163-172 [Abstract] [Full Text]  
  • Reljic, R., Wagner, S. D., Peakman, L. J., Fearon, D. T. (2000). Suppression of Signal Transducer and Activator of Transcription 3-dependent B Lymphocyte Terminal Differentiation by BCL-6. JEM 192: 1841-1848 [Abstract] [Full Text]  
  • Reeves, R., Leonard, W. J., Nissen, M. S. (2000). Binding of HMG-I(Y) Imparts Architectural Specificity to a Positioned Nucleosome on the Promoter of the Human Interleukin-2 Receptor alpha Gene. Mol. Cell. Biol. 20: 4666-4679 [Abstract] [Full Text]  
  • Ehret, G. B., Reichenbach, P., Schindler, U., Horvath, C. M., Fritz, S., Nabholz, M., Bucher, P. (2001). DNA Binding Specificity of Different STAT Proteins. COMPARISON OF IN VITRO SPECIFICITY WITH NATURAL TARGET SITES. J. Biol. Chem. 276: 6675-6688 [Abstract] [Full Text]